Felip, E., Wakelee, H. A., Fu, C., Deng, Y., Masson, F., Gitlitz, B. (2026). Reply to: “Improving the Reporting of Long-Term Effects in the IMpower010 Trial” and “Adjuvant Atezolizumab in Early-Stage Non-Small Cell Lung Cancer: Signals, Silences, and the Need for Methodological Clarity”. Journal of Clinical Oncology. https://doi.org/10.1200/jco-25-02102